Davide Rossi
Davide Rossi is head of the Experimental Hematology research program at the Institute of Oncology Research, Deputy Head of the Division of Hematology and co-chair of the Clinical Lymphoid Tumors Investigation Program at the Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
Clinical focus and interest:
Professor Rossi’s research focuses on lymphomas and chronic lymphocytic leukemia.
Experience:
Professor Rossi obtained his specialization in internal medicine and his PhD in clinical and experimental medicine at the University of Eastern Piedmont, Turin, Italy, where he served as Professor of Hematology until 2015. In 2015 Prof. Rossi moved to the Institute of Oncology Research in Switzerland.
Affiliations:
Professor Rossi has more than 330 publications in international peer-reviewed journals. He is also the principal investigator of national and international clinical trials in the field of chronic lymphocytic leukemia. Professor Rossi contributed to the development of chronic lymphocytic leukemia guidelines and co-authored the 2016 WHO Classification of Hematologic Malignancies. He serves as a member of several editorial boards: Blood (the official journal of the American Society of Hematology), Blood Cancer Discovery, and HaemaSphere (the official journal of the European Hematology Association). He is a member of the organizing committee of the International Conference on Malignant Lymphoma (ICML) and of the congress of the European Hematology Association (EHA). Professor Rossi’s research is funded by grants from the European Research Council, Swiss National Fund, Oncosuisse, Leukemia and Lymphoma Society, Fond’Action and Dr. Ettore Balli Foundation.